This review examines the genetic diversity of Chlamydia trachomatis and provides new insights that may be helpful in developing improved management strategies.

Genetic Variation in C. trachomatis A number of chlamydial virulence factors, such as the chlamydial protease activity factor (CPAF/CT858) and the GroEL (CT110)–GroES (CT111) operon, apparently ...

Sanofi is preparing to start human testing of its chlamydia vaccine, now fast-tracked by the FDA, that it hopes will be the first to reach the market.

Chlamydia trachomatis was isolated from liver biopsy specimens on two separate occasions in a young, sexually inactive patient with a 10 month history of recurrent episodes of fever, chills, and ...

It can take anywhere from a day to several months after exposure to a sexually transmitted disease before symptoms appear.

Doxycycline can treat certain urinary tract infections (UTIs), especially those that are caused by atypical or resistant bacteria, such as Chlamydia trachomatis. When effective, it may start relieving ...

Upon infection by an intracellular pathogen, host cells activate apoptotic pathways to limit pathogen replication. Consequently, efficient proliferation of the obligate intracellular pathogen ...

Chlamydia (Chlamydia trachomatis infection) Date of last revision/review: May 2008 National notification Only confirmed cases of disease should be notified. Type of surveillance Routine case-by-case ...

Submit a sample to the lab.Home → Health Professionals → Professional Testing Services → Clinical Microbiology → Submitting Samples ...